Management of Cancer Medication-Related Infusion Reactions
The objective of this guideline is to facilitate a standardized approach to cancer medication-related infusion reactions in Ontario. The guideline is informed by best available evidence and expert consensus, and provides recommendations on assessment, prophylaxis, acute management, and re-challenge (including desensitization). Supporting resources for healthcare providers include an acute management algorithm, a drug table, and a desensitization protocol calculation tool. A patient-information sheet has been developed based on health literacy best practices and patient and caregiver input.
Adult patients receiving systemic treatment.
Intended Guideline Users
Clinicians involved in the care of patients receiving systemic treatment (Physicians, Pharmacists, Nurses)